NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising cream may help kids with vitiligo regain skin color
Disease control Recruiting nowThis study tests a cream called ruxolitinib in children aged 6 to 12 with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the cream can safely and effectively bring back color, especially on the face. About 250 children will take pa…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Promising cream trial offers hope for kids with vitiligo
Disease control Recruiting nowThis study tests a cream called ruxolitinib to see if it can safely and effectively restore skin color in children with nonsegmental vitiligo, a condition where the skin loses its color in patches. About 180 children will apply the cream daily for up to 52 weeks. The goal is to m…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 04:11 UTC
-
Promising new combo for vitiligo: can a drug boost light Therapy's power?
Disease control Recruiting nowThis study tests whether adding an investigational drug called Melanotan II to standard light therapy helps restore skin color in adults with stable vitiligo. About 60 participants will receive either the drug or a placebo along with light treatments. The goal is to see if the co…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Can a Once-Daily pill bring back lost skin pigment?
Disease control Recruiting nowThis study tests a daily pill called zasocitinib for adults with nonsegmental vitiligo, a condition where the immune system attacks pigment cells, causing white patches. About 200 participants will receive either the drug or a placebo for up to a year. The goal is to see if the d…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 12, 2026 13:41 UTC